<DOC>
	<DOCNO>NCT02394379</DOCNO>
	<brief_summary>To evaluate incidence IOL vaulting ( ie , position change ) Trulign™ Toric IOL follow cataract surgery .</brief_summary>
	<brief_title>Post Approval Study Evaluate Trulign™ Toric Posterior Chamber IOL</brief_title>
	<detailed_description>The objective post approval safety study evaluate incidence IOL vaulting ( ie , position change ) Trulign™ Toric IOL follow cataract surgery three year post implantation .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<criteria>Subjects able willing comply followup schedule Subjects must clinically document diagnosis agerelated cataract consider amenable treatment standard phacoemulsification/extracapsular cataract extraction Subjects must require lens power 4 33 D Subjects must Best Corrected Visual Acuity ( BCVA ) equal bad 20/40 , without glare source Subjects anterior segment pathology study eye likely increase risk complication phacoemulsification cataract surgery Subjects associate ocular condition could affect stability IOL Subjects clinically significant irregular corneal astigmatism study eye</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>